Also trades as: 0H8T.L (LSE) · $vol 0M
ACRS NASDAQ
Aclaris Therapeutics, Inc.
1W: -5.4%
1M: +3.4%
3M: +40.1%
YTD: +57.6%
1Y: +236.3%
3Y: -44.5%
5Y: -78.6%
$4.52
-0.02 (-0.44%)
After Hours: $4.63 (+0.11, +2.43%)
Weekly Expected Move ±8.4%
$4
$4
$5
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$8M
Revenue
-52.9% YoY
$-70M
Net Income
+46.5% YoY
$-52M
Free Cash Flow
-8.5% YoY
80.2%
Gross Margin
-1111.8%
Op. Margin
-993.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-53.9%
ROA-36.6%
ROIC-440.1%
Valuation
P/E-8.3
P/B4.0
EV/EBITDA-5.4
Leverage
Debt/Equity0.02
Current Ratio5.28
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z-3.93
Beneish M7.62